---
title: "REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSES"
ocid: "ocds-h6vhtk-02a25c"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a25c"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a25c.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a25c.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BUSINESS ENERGY AND INDUSTRIAL STRATEGY"
published: "2021-04-01"
---

# REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSES

Buyer: BUSINESS ENERGY AND INDUSTRIAL STRATEGY  
Current stage: Award  
OCID: ocds-h6vhtk-02a25c

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a25c)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02a25c.json)

## Summary

The procurement process involves the Business Energy and Industrial Strategy as the contracting authority, seeking to establish a supply agreement for REGN-COV2 aimed at pandemic purposes. This tender, classified under the pharmaceutical products category, was initiated on 1st April 2021 and has reached the award stage, with the contract signed on 5th March 2021. The procurement method used was a limited one, allowing for direct award due to extreme urgency related to the ongoing global health crisis. The procurement is located in the UK, highlighting the immediate need for effective pandemic response solutions.

This tender presents significant opportunities for businesses, particularly those specialising in pharmaceutical research, supply chain logistics, and health-related product manufacturing. Companies that can meet the urgent demand for COVID-19 treatment solutions are particularly well-suited to compete in this procurement process. Engaging in such contracts can enhance a business's portfolio, improve market presence, and contribute to addressing critical public health needs during this challenging time.

## Notice

Procurement for REGN-COV2.

### Lot Information

Lot 1

Procurement for REGN-COV2. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vendors and (iii) impact fair competition between vendors .

### Procurement Information

Our position, after reviewing the advice from counsel, is that under the unforeseen current global public health crisis there is a strong argument that the direct award of a contract with Roche is compliant with current PCR regulations in respect to section 32(2)(c). Firstly, the urgent award to Roche is strictly necessary to prevent significant loss of life, disease, and protracted periods of continued economic stress. Delay in acquiring binding assurances to reserves of antibody doses would pose an imminent risk for long term procurement of a antibody to combat the Covid-19 pandemic. Therefore, the UKs adoption of a protectionist approach to acquiring the Regeneron antibody via a direct award is fully justified under PCR regulation 32(2)(c).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/006891-2021 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 1 Apr 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 5 Mar 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BUSINESS ENERGY AND INDUSTRIAL STRATEGY |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0ET |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | TLL Wales |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 1 Apr 2021 at 17:14 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/006891-2021

## Notice URLs

- https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a25c. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02a25c.json.